Clinical Evidence A study published in the New England Journal of Medicine followed 47 MCAS patients : 89% showed improvement in symptoms, including allergic, neurologic, digestive, and inflammation-related reactions Improvements happened within hours to days Only 13% experienced weight loss , and none became underweight Consistency is crucial
Studies were divided in cognitive disorders, substance-use disorders, psychotic disorders, mood and anxiety disorders, and eating disorders
At the same time, reduced dosing may also influence how well treatment works
I see patients rationing their medication, taking half doses just to keep some level of the drug in their system rather than stopping cold turkey
Communication delays from the medical team
Lifestyle Integration Requirements During GLP-1 use, nutritional and medical management of gastrointestinal side effects is critical, as is navigating altered dietary preferences and intakes, preventing nutrient deficiencies, preserving muscle and bone mass through resistance training and appropriate diet, and complementary lifestyle interventions [72]